The study also reported a 42% lower risk of psychiatric hospitalizations and work absences during periods when patients were ...

GLP-1 weight-loss drugs with semaglutide were associated with a lower risk of depression, anxiety, substance use disorders, ...

A new analysis represents the largest effort yet to systematically parse all the data from high-quality clinical trials on cannabis and mental health. The evidence is lacking.

Adolescence, the stage of development between childhood and adulthood, is characterized by many profound physical, mental, and emotional changes. During this critical stage, young people can ...

Screening for alcohol use may help identify patients that should receive further screening for adverse mental health conditions and other substance use. Investigators found high alcohol used scores ...

Hello and welcome! My name is Adrian Harris, and I'm so glad you're here. I create a safe and welcoming space where you can feel truly seen and heard. I believe that therapy is a collaborative journey ...

Increasing numbers of Australians are using medicinal cannabis for anxiety, depression, insomnia, substance disorders and ...

There was some evidence that cannabinoids can reduce symptoms of cannabis use disorder, insomnia, tic or Tourette's syndrome, and autism spectrum disorder, but the quality of this evidence was ...

Is anxiety, depression, or problem drinking getting in the way of your personal or professional success? Does constant worry keep you from falling asleep? Is your relationship in trouble? In therapy, ...